Scientists track kids for 15 years after gene therapy to uncover hidden risks
NCT ID NCT02315599
Summary
This study aims to understand the long-term safety of gene therapies used to treat childhood cancers. It will follow up to 500 children and young adults for 15 years after they received gene therapy in other National Cancer Institute trials. Researchers will check participants' health regularly through exams, blood tests, and questionnaires to look for any delayed side effects that might appear months or years later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.